Op2Lysis patent granted in Japan

Op2Lysis patent granted in Japan

An additional step was achieved on last October, with Japan granting the patent that protects O2L-001. After US, this is the second large geographic area of patent protection. This decision strengthens our development and our international strategy.

http://www.theraprot.fr/op2lysis/wp-content/uploads/2017/11/Op2Lysis-new-thrombolytic-agents-patent-to-be-granted-in-Japan-VF.pdf

About the author

Tiffany Le Carff administrator